Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 4% | |
natural killer cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of SLC25A20 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 1289.60 | 359 / 359 | 100% | 31.37 | 286 / 286 |
kidney | 100% | 1515.07 | 89 / 89 | 100% | 31.00 | 900 / 901 |
liver | 100% | 4939.50 | 226 / 226 | 100% | 84.72 | 405 / 406 |
intestine | 100% | 1861.14 | 965 / 966 | 99% | 33.12 | 524 / 527 |
breast | 100% | 1687.80 | 458 / 459 | 99% | 35.54 | 1110 / 1118 |
pancreas | 100% | 1138.86 | 327 / 328 | 99% | 33.29 | 176 / 178 |
adrenal gland | 100% | 2652.62 | 258 / 258 | 98% | 35.53 | 226 / 230 |
thymus | 98% | 1035.55 | 641 / 653 | 100% | 29.92 | 602 / 605 |
skin | 99% | 861.66 | 1787 / 1809 | 99% | 30.97 | 466 / 472 |
lung | 99% | 1128.78 | 572 / 578 | 98% | 25.25 | 1135 / 1155 |
prostate | 99% | 1029.69 | 243 / 245 | 97% | 39.53 | 488 / 502 |
bladder | 100% | 1058.43 | 21 / 21 | 95% | 24.90 | 480 / 504 |
uterus | 97% | 864.85 | 165 / 170 | 97% | 21.53 | 443 / 459 |
ovary | 88% | 528.16 | 159 / 180 | 99% | 21.73 | 427 / 430 |
esophagus | 98% | 1018.98 | 1420 / 1445 | 87% | 17.50 | 160 / 183 |
brain | 89% | 759.44 | 2357 / 2642 | 95% | 32.56 | 667 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 48.48 | 29 / 29 |
muscle | 100% | 3342.26 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1946.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.80 | 1 / 1 |
adipose | 100% | 1748.08 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 961.90 | 1320 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 2716.85 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 1241.38 | 882 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 12.35 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006839 | Biological process | mitochondrial transport |
GO_1902616 | Biological process | acyl carnitine transmembrane transport |
GO_1902603 | Biological process | carnitine transmembrane transport |
GO_0006853 | Biological process | carnitine shuttle |
GO_0001701 | Biological process | in utero embryonic development |
GO_0005740 | Cellular component | mitochondrial envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0015227 | Molecular function | acyl carnitine transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC25A20 |
Protein name | Solute carrier family 25 member 20 Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20) |
Synonyms | CAC CACT |
Description | FUNCTION: Mediates the electroneutral exchange of acylcarnitines (O-acyl-(R)-carnitine or L-acylcarnitine) of different acyl chain lengths (ranging from O-acetyl-(R)-carnitine to long-chain O-acyl-(R)-carnitines) with free carnitine ((R)-carnitine or L-carnitine) across the mitochondrial inner membrane, via a ping-pong mechanism (Probable). Key player in the mitochondrial oxidation pathway, it translocates the fatty acids in the form of acylcarnitines into the mitochondrial matrix, where the carnitine palmitoyltransferase 2 (CPT-2) activates them to undergo fatty acid beta-oxidation (Probable). Catalyzes the unidirectional transport (uniport) of carnitine at lower rates than the antiport (exchange) . . |
Accessions | ENST00000440964.1 ENST00000319017.5 C9JPE1 ENST00000430379.5 O43772 F8WEF6 |